- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: plasma glucagon-like peptide-1 levels
Total 357 results
-
Novo Nordisk A/SActive, not recruitingDiabetes Mellitus, Type 2United States, Spain, Netherlands, United Kingdom, Canada, India, Austria, Korea, Republic of, Germany, Brazil, Malaysia, Thailand, Japan, Argentina, Serbia, Turkey, China, Russian Federation, Taiwan, Hong Kong, Mexico, Romania, Ukr... and more
-
Novo Nordisk A/SActive, not recruitingDiabetes Mellitus, Type 2Spain, United Kingdom, United States, Australia, India, Canada, Turkey, Netherlands, Italy, Poland, China, Germany, Malaysia, Israel, Hungary, Ukraine, Japan, South Africa, Russian Federation, Brazil, France, Bulgaria, Belgium, Thailand, Gree... and more
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Germany
-
Xeris PharmaceuticalsCompleted
-
University of CopenhagenHvidovre University HospitalCompleted
-
University of MinnesotaCystic Fibrosis FoundationRecruiting
-
University Hospital Bispebjerg and FrederiksbergCompletedDrug Overdose | Overdose of Beta-adrenergic Blocking DrugDenmark
-
Sciwind Biosciences APAC CO Pty. Ltd.Hangzhou Sciwind Biosciences Co., Ltd.CompletedObesity | Type 2 Diabetes Mellitus | Nonalcoholic SteatohepatitisAustralia
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Germany
-
Vanderbilt University Medical CenterRecruitingType 1 DiabetesUnited States
-
Novo Nordisk A/SRecruitingDiabetes Mellitus, Type 2United States, Malaysia, United Kingdom, Australia, Netherlands, Portugal, Austria, Israel, India, Greece, Lebanon, Mexico, New Zealand, North Macedonia, Puerto Rico, Romania, Russian Federation, Ukraine, Morocco, Belgium, Czechia, Taiw...
-
Novo Nordisk A/SCompletedHealthy ParticipantsUnited States, Canada
-
State University of New York at BuffaloNational Center for Advancing Translational Sciences (NCATS)Active, not recruiting
-
Novo Nordisk A/SCompleted
-
Yale UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Novo...Not yet recruitingObesity | Diabetes type1United States
-
Capital Medical UniversityNot yet recruitingIdiopathic Intracranial Hypertension
-
Novo Nordisk A/SCompletedObesity | OverweightGermany, Denmark, Canada, United States, Russian Federation, Finland, Poland, France, Japan
-
Massachusetts General HospitalBoston UniversityTerminatedDiabetes Mellitus Type 1United States
-
The Affiliated Hospital of Xuzhou Medical UniversityRecruitingType 2 Diabetes MellitusChina
-
Novo Nordisk A/SNot yet recruiting
-
University of WashingtonNovo Nordisk A/SRecruitingDiabetes Mellitus, Type 2 | Stroke (CVA) or Transient Ischemic AttackUnited States
-
University of HullNot yet recruitingPolycystic Ovary SyndromeUnited Kingdom
-
Novo Nordisk A/SActive, not recruitingObesityFinland, Spain, Taiwan, Korea, Republic of, United States, Netherlands, India, Japan, United Kingdom, Germany, Serbia, Denmark, Canada, Bulgaria, Australia, South Africa, Italy, Poland, Mexico, Belgium, Turkey, France, Argentina
-
Novo Nordisk A/SRecruiting
-
Boehringer IngelheimNot yet recruiting
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2Australia, Mexico, Taiwan, United States, Israel, Russian Federation, Slovakia, Ukraine, Guatemala, Peru, Romania
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.RecruitingType 2 Diabetes MellitusChina
-
Novo Nordisk A/SRecruitingType 2 Diabetes MellitusKorea, Republic of, United States, Hungary, Serbia, Spain, China, Australia, Finland, United Kingdom, Italy, Denmark, Canada, Taiwan, Poland, Germany, Sweden, South Africa, Argentina, Brazil, Bulgaria, Japan, Mexico, Turkey, Greece, Col... and more
-
Odense University HospitalRecruitingType 2 Diabetes | OsteopeniaDenmark
-
University of Colorado, DenverNational Heart, Lung, and Blood Institute (NHLBI)RecruitingDiabetes Mellitus, Type 1United States
-
Jan FrystykRegion of Southern Denmark; Region Zealand; Steno Diabetes Center Sjaelland; Steno...RecruitingSchizophrenia | Prediabetic StateDenmark
-
Novo Nordisk A/SActive, not recruitingObesity | Overweight | Type 2 Diabetes MellitusUnited States, India, Poland, Malaysia, United Kingdom, Japan, Thailand, Germany, Austria, Canada, Hungary, Ireland, Puerto Rico
-
Eli Lilly and CompanyCompletedGlucose Metabolism Disorders | Diabetes Mellitus, Type 2 | Diabetes Mellitus | Endocrine System Diseases | Metabolic Disease | Type 2 Diabetes Mellitus (T2DM) | Hypoglycemic AgentsJapan
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2Germany, United Kingdom
-
Christina KruuseRecruitingIschemic StrokeDenmark
-
Janssen Research & Development, LLCCompletedCardiovascular Diseases | Diabetes Mellitus, Type 2United States
-
GlyPharma TherapeuticsVectivBio AGCompletedShort Bowel SyndromeDenmark
-
Papworth Hospital NHS Foundation TrustUnknownMyocardial Infarction | Angina Pectoris | Coronary Heart Disease | Reperfusion InjuryUnited Kingdom
-
Johns Hopkins UniversityTerminated
-
Centre Hospitalier Universitaire de NiceRecruiting
-
University of CopenhagenHvidovre University HospitalRecruitingSpinal Cord InjuriesDenmark
-
Rigshospitalet, DenmarkOdense University Hospital; Aarhus University HospitalRecruitingHyperglycemia | Diabetes | Renal Transplant Complication Primary Non-FunctionDenmark
-
University of OxfordNovo Nordisk A/SRecruitingDiabetes Mellitus, Type 2United Kingdom
-
Jens D Hove, MD,PHDRecruitingObesity | Weight Loss | Chronic Heart Failure | Heart Failure With Reduced Ejection FractionDenmark
-
Mayo ClinicUnited States Department of DefenseRecruitingObesity | Cardiomyopathy | Heart Failure With Preserved Ejection Fraction (HFpEF)United States
-
Yale UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)RecruitingType 2 Diabetes Mellitus | Obesity, Childhood | Impaired Glucose Tolerance | Non-Alcoholic Fatty Liver DiseaseUnited States
-
Novo Nordisk A/SCompletedOverweight and ObesityKorea, Republic of, Japan
-
Klaus Gottlob MüllerNovo Nordisk A/S; Independent Research Fund DenmarkNot yet recruitingInflammation | Chemotherapeutic Toxicity | Intestinal Mucositis
-
University of Maryland, BaltimoreRecruiting
-
Jaeb Center for Health ResearchXeris PharmaceuticalsCompletedDiabetes Mellitus, Type 1United States